Verastem (VSTM) Times Interest Earned (2011 - 2026)
Verastem's (VSTM) quarterly Times Interest Earned came in at -$52.51 in Q1 2026, down 41.7% year-on-year from -$90.07 in Q1 2025, and up 47.46% quarter-over-quarter from -$99.94 in Q4 2025.
Verastem (VSTM) Times Interest Earned (2011 - 2026) Analysis & Trends
Verastem's Times Interest Earned history runs 16 years deep, the most recent figure standing at -$52.51 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 41.7% year-over-year to -$52.51 in Q1 2026; TTM through Mar 2026 was -$199.83, a 81.73% decrease from a year earlier, with the FY2025 full-year figure at -$26.73, down 6.09% from the prior year.
- Times Interest Earned climbed to -$52.51 in Q1 2026 per VSTM's latest filing, from -$99.94 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$3.98 in Q2 2025 and bottomed at -$99.94 in Q4 2025.
- The 5-year median for Times Interest Earned is -$25.15 (2023), against an average of -$34.29.
- Biggest YoY gain for Times Interest Earned was 98.59% in 2022; the steepest drop was 3861.11% in 2022.
- Year by year, Times Interest Earned stood at -$23.27 in 2022, then slumped by 291.31% to -$91.05 in 2023, then soared by 69.72% to -$27.57 in 2024, then sank by 262.55% to -$99.94 in 2025, then soared by 47.46% to -$52.51 in 2026.
- Per Business Quant, the three latest VSTM Times Interest Earned figures stand at -$52.51 (Q1 2026), -$99.94 (Q4 2025), and -$8.58 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -52.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.51 |
| Dec 31, 2025 | -99.94 |
| Sep 30, 2025 | -8.58 |
| Jun 30, 2025 | -3.98 |
| Mar 31, 2025 | -37.06 |
| Dec 31, 2024 | -27.57 |
| Sep 30, 2024 | -32.26 |
| Jun 30, 2024 | -16.06 |
| Mar 31, 2024 | -6.18 |
| Dec 31, 2023 | -91.05 |
| Sep 30, 2023 | -18.87 |
| Jun 30, 2023 | -18.10 |
| Mar 31, 2023 | -25.15 |
| Dec 31, 2022 | -23.27 |
| Sep 30, 2022 | -22.79 |
| Jun 30, 2022 | -33.44 |
| Mar 31, 2022 | -66.07 |
| Dec 31, 2021 | -1,651.10 |
| Sep 30, 2021 | -1.46 |
| Jun 30, 2021 | -0.84 |